Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2024 | Developing and validating a trustworthy AI model for clinical practice

Leonardo Provenzano • 16 May 2024
ESMO Breast 2024
Breast Cancer

Leonardo Provenzano, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, discusses developing a reliable artificial intelligence (AI) model for clinical practice by integrating extensive data and validating it prospectively. This model aims to identify patient groups with varying prognoses, allowing for tailored treatment strategies, including potential escalation or de-escalation of therapies. This interview took place at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Leonardo Provenzano

Predicting early progression in HR+/HER2- breast cancer with AI models
4:20
Predicting early progression in HR+/HER2- breast cancer with AI models
Leonardo Provenzano • 16 May 2024

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026
The content of VJOncology is intended for healthcare professionals